References
- Sullivan LB, Gui DY, Vander Heiden MG. Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. Nat Rev Cancer. 2016;16(11):680–93. doi:https://doi.org/10.1038/nrc.2016.85
- Scharping NE, Delgoffe GM. Tumor microenvironment metabolism: a new checkpoint for anti-tumor immunity. Vaccines. 2016;4(4):46. doi:https://doi.org/10.3390/vaccines4040046
- Mashhoody T, Rastegar K, Zal F. Perindopril may improve the hippocampal reduced glutathione content in rats. Adv Pharmaceut Bull. 2014;4(2):155.
- Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–62. doi:https://doi.org/10.1016/j.cub.2014.03.034
- Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, Liang X. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37(1):266. doi:https://doi.org/10.1186/s13046-018-0909-x
- Chen W, Li P, Liu Y, Yang Y, Ye X, Zhang F, Huang H. Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells. J Exp Clin Cancer Res. 2018;37(1):309. doi:https://doi.org/10.1186/s13046-018-0987-9
- Hawk MA, McCallister C, Schafer ZT. Antioxidant activity during tumor progression: a necessity for the survival of cancer cells?. Cancers. 2016;8(10):92. doi:https://doi.org/10.3390/cancers8100092
- Murakami S, Motohashi H. Roles of Nrf2 in cell proliferation and differentiation. Free Radic Biol Med. 2015;88(Pt B):168–78. doi:https://doi.org/10.1016/j.freeradbiomed.2015.06.030
- Lu K, Alcivar AL, Ma J, Foo TK, Zywea S, Mahdi A, Huo Y, Kensler TW, Gatza ML, Xia B, et al. NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction. Cancer Res. 2017;77(11):2881–92. doi:https://doi.org/10.1158/0008-5472.CAN-16-2204
- Beury DW, Carter KA, Nelson C, Sinha P, Hanson E, Nyandjo M, Fitzgerald PJ, Majeed A, Wali N, Ostrand-Rosenberg S, et al. Myeloid-derived suppressor cell survival and function are regulated by the transcription factor Nrf2. J Immunol. 2016;196(8):3470–8. doi:https://doi.org/10.4049/jimmunol.1501785
- Chartoumpekis DV, Wakabayashi N, Kensler TW. Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism. Biochem Soc Trans. 2015;43(4):639–44. doi:https://doi.org/10.1042/BST20150049
- Leinonen HM, Kansanen E, Polonen P, Heinaniemi M, Levonen AL. Role of the Keap1-Nrf2 pathway in cancer. Adv Cancer Res. 2014;122:281–320. doi:https://doi.org/10.1016/B978-0-12-420117-0.00008-6
- Fan Z, Wirth A-K, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 2017;6(8):e371. doi:https://doi.org/10.1038/oncsis.2017.65
- Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 2013;1:45–9. doi:https://doi.org/10.1016/j.redox.2012.10.001
- Jeddi F, Soozangar N, Sadeghi MR, Somi MH, Samadi N. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance. DNA Repair (Amst).). 2017;54:13–21. doi:https://doi.org/10.1016/j.dnarep.2017.03.008
- Assaei R, Zal F, Mostafavi-Pour Z, Dabbaghmanesh MH, Geramizadeh B, Ranjbar Omrani GH, Pajouhi N. Hepatoprotective effect of Satureja khuzestanica essential oil and vitamin E in experimental hyperthyroid rats: evidence for role of antioxidant effect. Iran J Med Sci. 2014;39(5):459–66.
- Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, Lazar M, Cotzia P, Draganova-Tacheva R, Lin Z, et al. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-acetylcysteine in breast cancer. Semin Oncol. 2017;44(3):226–32. doi:https://doi.org/10.1053/j.seminoncol.2017.10.001
- Mastrangelo D, Pelosi E, Castelli G, Lo-Coco F, Testa U. Mechanisms of anti-cancer effects of ascorbate: cytotoxic activity and epigenetic modulation. Blood Cells Mol Dis. 2018;69:57–64. doi:https://doi.org/10.1016/j.bcmd.2017.09.005
- Park S, Ahn S, Shin Y, Yang Y, Yeom CH. Vitamin C in Cancer: a metabolomics perspective. Front Physiol. 2018;9:762. doi:https://doi.org/10.3389/fphys.2018.00762
- Blaszczak W, Barczak W, Masternak J, Kopczyński P, Zhitkovich A, Rubiś B. Vitamin C as a modulator of the response to cancer therapy. Molecules (Basel, Switzerland). 2019;24(3):453. doi:https://doi.org/10.3390/molecules24030453
- Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio IIC, Giannopoulou EG, Rago C, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 2015;350(6266):1391–6. doi:https://doi.org/10.1126/science.aaa5004
- Saw CLL, Guo Y, Yang AY, Paredes-Gonzalez X, Ramirez C, Pung D, Kong A-NT. The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway. Food and chemical toxicology: an international journal published for the British Industrial. Food Chem Toxicol. 2014;72:303–11. doi:https://doi.org/10.1016/j.fct.2014.07.038
- Robaszkiewicz A, Balcerczyk A, Bartosz G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol Int. 2007;31(10):1245–50. doi:https://doi.org/10.1016/j.cellbi.2007.04.009
- Lee YJ, Lee DM, Lee SH. Nrf2 expression and apoptosis in quercetin-treated malignant mesothelioma cells. Mol Cells. 2015;38(5):416–25. doi:https://doi.org/10.14348/molcells.2015.2268
- Granado-Serrano AB, Martin MA, Bravo L, Goya L, Ramos S. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact. 2012;195(2):154–64. doi:https://doi.org/10.1016/j.cbi.2011.12.005
- Yarahmadi A, Zal F, Bolouki A. Protective effects of quercetin on nicotine induced oxidative stress in 'HepG2 cells'. Toxicol Mech Methods. 2017;27(8):609–14. doi:https://doi.org/10.1080/15376516.2017.1344338
- Miladpour B, Rasti M, Owji AA, Mostafavipour Z, Khoshdel Z, Noorafshan A, Zal F. Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro. J Endocrinol Invest. 2017;40(5):513–21. doi:https://doi.org/10.1007/s40618-016-0592-8
- Khadrawy O, Gebremedhn S, Salilew-Wondim D, Taqi M, Neuhoff C, Tholen E, Hoelker M, Schellander K, Tesfaye D. Endogenous and exogenous modulation of Nrf2 mediated oxidative stress response in bovine granulosa cells: potential implication for ovarian function. IJMS. 2019;20(7):1635. doi:https://doi.org/10.3390/ijms20071635
- Steiner JL, Davis JM, McClellan JL, Enos RT, Carson JA, Fayad R, Nagarkatti M, Nagarkatti PS, Altomare D, Creek KE, et al. Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer. Cancer Biol Therapy. 2014;15(11):1456–67. doi:https://doi.org/10.4161/15384047.2014.955444
- Mostafavi-Pour Z, Ramezani F, Keshavarzi F, Samadi N. The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cells. Oncol Lett. 2017;13(3):1965–73. doi:https://doi.org/10.3892/ol.2017.5619
- Pfaffl MW. Quantification strategies in real-time PCR. AZ of Quantitative PCR. 2004;1:89–113.
- Sardarian A, Andisheh Tadbir A, Zal F, Amini F, Jafarian A, Khademi F, Mostafavi-Pour Z. Altered oxidative status and integrin expression in cyclosporine A-treated oral epithelial cells. Toxicol Mech Methods. 2015;25(2):98–104. doi:https://doi.org/10.3109/15376516.2014.990595
- Zal F, Taheri R, Khademi F, Keshavarz E, Rajabi S, Mostafavi-Pour Z. The combined effect of furosemide and propranolol on GSH homeostasis in ACHN renal cells. Toxicol Mech Methods. 2014;24(6):412–6. doi:https://doi.org/10.3109/15376516.2014.926437
- Ryter SW, Kvam E, Tyrrell RM. Heme oxygenase activity. In: Current methods and applications. Methods in molecular biology. Clifton, NJ; 2000. 99:p. 369–91.
- Fontana F, Raimondi M, Marzagalli M, Sommariva M, Limonta P, Gagliano N. Epithelial-to-mesenchymal transition markers and CD44 isoforms are differently expressed in 2D and 3D cell cultures of prostate cancer cells. Cells. 2019;8(2):143. doi:https://doi.org/10.3390/cells8020143
- Jayakumar S, Kunwar A, Sandur SK, Pandey BN, Chaubey RC. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity. Biochim Biophys Acta. 2014;1840(1):485–94. doi:https://doi.org/10.1016/j.bbagen.2013.10.006
- Klongpityapong P, Supabphol R, Supabphol A. Antioxidant effects of gamma-oryzanol on human prostate cancer cells. Asian Pac J Cancer Prev. 2013;14(9):5421–5. doi:https://doi.org/10.7314/apjcp.2013.14.9.5421
- Nair HK, Rao KV, Aalinkeel R, Mahajan S, Chawda R, Schwartz SA. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004;11(1):63–9. doi:https://doi.org/10.1128/cdli.11.1.63-69.2004
- Ward AB, Mir H, Kapur N, Gales DN, Carriere PP, Singh S. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncol. 2018;16(1):108. doi:https://doi.org/10.1186/s12957-018-1400-z
- Liang L, Gao C, Luo M, Wang W, Zhao C, Zu Y, Efferth T, Fu Y. Dihydroquercetin (DHQ) induced HO-1 and NQO1 expression against oxidative stress through the Nrf2-dependent antioxidant pathway. J Agric Food Chem. 2013;61(11):2755–61. doi:https://doi.org/10.1021/jf304768p
- Ramezani F, Samadi N, Mostafavi-Pour Z. Sequential therapy of breast cancer cell lines with Vitamin C and quercetin improves the efficacy of chemotherapeutic drugs. Nutr Cancer. 2017;69(6):881–91. doi:https://doi.org/10.1080/01635581.2017.1339813